This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Xenon Pharmaceuticals Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Innovations of Matthew David Tandy
Introduction
Matthew David Tandy is an accomplished inventor based in Burnaby, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective potassium channel modulators. With a total of 2 patents, Tandy's work is recognized for its potential impact on medical treatments.
Latest Patents
Tandy's latest patents focus on solid state crystalline forms of a selective potassium channel modulator. The present disclosure provides solid state forms of this modulator and pharmaceutical compositions that include these solid state crystalline forms along with pharmaceutically acceptable excipients. Additionally, the patents detail methods for preparing and utilizing these solid state forms and the associated pharmaceutical compositions.
Career Highlights
Matthew David Tandy is currently employed at Xenon Pharmaceuticals Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science through the development of new therapeutic options.
Collaborations
Tandy collaborates with notable professionals in his field, including Paul Robert Bichler and Jean-Jacques Alexandre Cadieux. These collaborations enhance the research and development efforts at Xenon Pharmaceuticals Inc.
Conclusion
Matthew David Tandy is a prominent inventor whose work in the pharmaceutical industry is paving the way for new treatments. His innovative patents and collaborations reflect his dedication to improving healthcare solutions.